Simple Summary According to the 2020 World Health Organization classification, a giant cell
tumor of bone is an intermediate malignant bone tumor. Denosumab treatment before …

Aims Giant cell tumours (GCTs) of the proximal femur are rare, and there is no consensus
about the best method of filling the defect left by curettage. In this study, we compared the …

Aims Osteoarticular reconstruction of the distal femur in childhood has the advantage of
preserving the tibial physis. However, due to the small size of the distal femur, matching the …

Background There is no clear consensus on the optimal type of fixation in intercalary
allograft reconstruction. In this study, we aimed to compare the rate of most common …

Background Extended curettage has increasingly become the preferred treatment for giant
cell tumour of bone (GCTB), but the high recurrence rate after curettage poses a major …

Background In recent years, researchers have proposed a number of adjuvant methods for
extended curettage of giant cell tumors of the bone. However, various schemes have …

Aim As a locally destructive intermediate bone tumor with low incidence, high recurrence
rate, and difficulty in reconstruction, giant cell tumor of bone (GCTB) in the proximal femur …

Aims The epiphyseal approach to a chondroblastoma of the intercondylar notch of a child's
distal femur does not provide adequate exposure, thereby necessitating the removal of a …

Objective The aims of this work are to present a classification of “complex fracture” and
“simple fracture”, to compare their features, treatments and prognosis in patients with giant …

Background Giant cell tumor (GCT) is a benign tumor with progressive and destructive
characteristics involving metaphysis, with extension to the epiphyseal tissue, en-bloc …